Related Experiment Videos
Alpha-helix mimicry of a beta-turn
G Mer1, E Kellenberger, J F Lefèvre
1CNRS - UPR 9003, Université Louis Pasteur, Ecole Supérieure de Biotechnologie de Strasbourg, Boulevard Sébastien Brant, Strasbourg - Illkirch, 67400, France. georges@scripps.edu
Journal of Molecular Biology
|August 12, 1998
Summary
Researchers mimicked cell adhesion sequences using alpha-helices instead of beta-turns. A designed miniprotein confirmed this helical mimicry is bioactive and structurally accurate.
Area of Science:
- Biochemistry
- Structural Biology
- Protein Design
Background:
- Cell adhesion is often mediated by specific amino acid sequences forming beta-turns.
- The RGDF sequence is crucial for certain cell adhesion processes.
- The structural similarity between beta-turns and alpha-helices presents an opportunity for biomimicry.
Purpose of the Study:
- To investigate if an alpha-helix can mimic the function of an RGDF beta-turn in cell adhesion.
- To design and construct a miniprotein that adopts a helical conformation with a shuffled RGDF sequence (RGXFD).
- To assess the bioactivity and structural integrity of the designed miniprotein.
Main Methods:
- Computational design of a miniprotein incorporating the RGXFD sequence.
- Chemical synthesis and construction of the designed miniprotein.
- Nuclear magnetic resonance (NMR) spectroscopy to verify the protein's folded structure.
Main Results:
- The three-dimensional structure of the RGDF beta-turn closely resembles a shuffled RGDF sequence (RGXFD) in an alpha-helical conformation.
- A designed miniprotein successfully arranged the RGXFD sequence into a defined helical structure.
- The designed helical miniprotein was found to be bioactive and folded correctly, as confirmed by NMR.
Conclusions:
- Alpha-helices can effectively mimic the recognition processes typically mediated by RGDF beta-turns.
- Protein design principles allow for the creation of helical structures that replicate beta-turn functions.
- This finding opens new avenues for designing bioactive peptides and proteins for therapeutic or research applications.